Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 9Gynecologic 3Tumor-Agnostic 2Thoracic 2Head & Neck 2Genitourinary 2Gastrointestinal 2Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1CNS 1

Conditions

Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 65Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Population Groups × Head & Neck × Clear all
NCT06318221 2024-03-19

Effects of Perioperative Immunonutrition in Patients With Head and Neck Cancer

TC Erciyes University

Phase NA Completed
34 enrolled
Head & Neck

Head and Neck Neoplasms

NCT01536223 2013-03-05

ESNCCT

Zhejiang Cancer Hospital

Phase 3 Unknown
400 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡